A detailed history of Sheets Smith Wealth Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sheets Smith Wealth Management holds 5,427 shares of BMY stock, worth $268,148. This represents 0.03% of its overall portfolio holdings.

Number of Shares
5,427
Previous 40,901 86.73%
Holding current value
$268,148
Previous $2.22 Million 89.86%
% of portfolio
0.03%
Previous 0.25%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$40.25 - $52.99 $1.43 Million - $1.88 Million
-35,474 Reduced 86.73%
5,427 $225,000
Q1 2024

May 08, 2024

SELL
$47.98 - $54.4 $1.01 Million - $1.15 Million
-21,107 Reduced 34.04%
40,901 $2.22 Million
Q4 2023

Feb 06, 2024

BUY
$48.48 - $57.85 $92,936 - $110,898
1,917 Added 3.19%
62,008 $3.18 Million
Q3 2023

Oct 23, 2023

SELL
$57.89 - $64.73 $106,922 - $119,556
-1,847 Reduced 2.98%
60,091 $3.49 Million
Q2 2023

Aug 09, 2023

SELL
$63.71 - $70.74 $2,930 - $3,254
-46 Reduced 0.07%
61,938 $3.96 Million
Q1 2023

May 26, 2023

BUY
$65.71 - $74.53 $4.07 Million - $4.61 Million
61,915 Added 89731.88%
61,984 $4.3 Million
Q1 2023

May 12, 2023

SELL
$65.71 - $74.53 $4.05 Million - $4.59 Million
-61,599 Reduced 99.89%
69 $4,000
Q4 2022

Mar 08, 2023

BUY
$68.48 - $81.09 $17,804 - $21,083
260 Added 0.42%
61,668 $4.44 Million
Q3 2022

Nov 01, 2022

BUY
$0.13 - $76.84 $11 - $6,915
90 Added 0.15%
61,408 $4.37 Million
Q2 2022

Jul 27, 2022

SELL
$72.62 - $79.98 $72,547 - $79,900
-999 Reduced 1.6%
61,318 $4.72 Million
Q1 2022

May 02, 2022

SELL
$61.48 - $73.72 $364,760 - $437,380
-5,933 Reduced 8.69%
62,317 $4.55 Million
Q4 2021

Jan 20, 2022

SELL
$53.63 - $62.52 $953,702 - $1.11 Million
-17,783 Reduced 20.67%
68,250 $4.26 Million
Q2 2021

Aug 03, 2021

BUY
$61.91 - $67.42 $30,335 - $33,035
490 Added 0.57%
86,033 $5.75 Million
Q1 2021

Apr 23, 2021

BUY
$59.34 - $66.74 $4.71 Million - $5.3 Million
79,415 Added 1295.94%
85,543 $5.4 Million
Q4 2020

Jan 13, 2021

SELL
$57.74 - $65.43 $598,013 - $677,658
-10,357 Reduced 62.83%
6,128 $380,000
Q3 2020

Oct 26, 2020

BUY
$57.43 - $63.64 $592,562 - $656,637
10,318 Added 167.31%
16,485 $994,000
Q2 2020

Jul 17, 2020

SELL
$54.82 - $64.09 $760,298 - $888,864
-13,869 Reduced 69.22%
6,167 $363,000
Q1 2020

Apr 28, 2020

SELL
$46.4 - $67.43 $256,406 - $372,618
-5,526 Reduced 21.62%
20,036 $1.12 Million
Q4 2019

Jan 24, 2020

BUY
$49.21 - $64.19 $1.26 Million - $1.64 Million
25,562 New
25,562 $1.63 Million
Q1 2019

May 13, 2019

SELL
$45.12 - $53.8 $681,312 - $812,380
-15,100 Closed
0 $0
Q2 2018

Jul 26, 2018

SELL
$50.53 - $62.98 $52,500 - $65,436
-1,039 Reduced 6.44%
15,100 $836,000
Q3 2017

Oct 12, 2017

BUY
$55.23 - $63.74 $891,356 - $1.03 Million
16,139
16,139 $1.03 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $105B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Sheets Smith Wealth Management Portfolio

Follow Sheets Smith Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sheets Smith Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Sheets Smith Wealth Management with notifications on news.